FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer
Clinical trial NCT02581462 · COMPLETED
Trial details
- NCT number
- NCT02581462
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-07-17
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.